Serum Lipoprotein Levels During Chlorthalidone Therapy: A Veterans Administration-National Heart, Lung, and Blood Institute Cooperative Study on Antihypertensive Therapy: Mild Hypertension

Anne I. Goldman, Bernard W Steele, Harold W. Schnaper, H. Mitchell Perry, Annette E. Fitz, Edward D. Frohlich

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

In a joint Veterans Administration-National Heart, Lung, and Blood Institute study of mild hypertension, 1,012 men and women, 21 to 50 years of age and with diastolic pressure from 85 to 105 mm Hg, were randomized into two double-blind treatment groups. Subjects in the active group received chlorthalidone or chlorthalidone plus reserpine, while the other subjects received matching placebo tablets. After one year of treatment, the chlorthalidone group had increases of 10.0±1.8 (SE) mg/dL in total cholesterol level, 9.8±5.2 mg/dL in triglyceride level, and 12.6±3.4 mg/dL in low-density lipoprotein-cholesterol level above the changes in the placebo group. There was no difference in high-density lipoprotein changes between the two groups (0.1±0.8 mg/dL). The possible net effect on risk of increasing lipid values while lowering pressure in the long-term treatment of mild hypertension with thiazides or related diuretics must be further evaluated.

Original languageEnglish (US)
Pages (from-to)1691-1695
Number of pages5
JournalJAMA - Journal of the American Medical Association
Volume244
Issue number15
DOIs
StatePublished - Oct 10 1980
Externally publishedYes

Fingerprint

Chlorthalidone
National Heart, Lung, and Blood Institute (U.S.)
United States Department of Veterans Affairs
Antihypertensive Agents
Lipoproteins
Hypertension
Serum
Placebos
Thiazides
Reserpine
HDL Lipoproteins
Diuretics
LDL Cholesterol
Tablets
Triglycerides
Therapeutics
Joints
Cholesterol
Blood Pressure
Lipids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Serum Lipoprotein Levels During Chlorthalidone Therapy : A Veterans Administration-National Heart, Lung, and Blood Institute Cooperative Study on Antihypertensive Therapy: Mild Hypertension. / Goldman, Anne I.; Steele, Bernard W; Schnaper, Harold W.; Perry, H. Mitchell; Fitz, Annette E.; Frohlich, Edward D.

In: JAMA - Journal of the American Medical Association, Vol. 244, No. 15, 10.10.1980, p. 1691-1695.

Research output: Contribution to journalArticle

Goldman, Anne I. ; Steele, Bernard W ; Schnaper, Harold W. ; Perry, H. Mitchell ; Fitz, Annette E. ; Frohlich, Edward D. / Serum Lipoprotein Levels During Chlorthalidone Therapy : A Veterans Administration-National Heart, Lung, and Blood Institute Cooperative Study on Antihypertensive Therapy: Mild Hypertension. In: JAMA - Journal of the American Medical Association. 1980 ; Vol. 244, No. 15. pp. 1691-1695.
@article{724d5c4950df4ade8381ae9e71631ff7,
title = "Serum Lipoprotein Levels During Chlorthalidone Therapy: A Veterans Administration-National Heart, Lung, and Blood Institute Cooperative Study on Antihypertensive Therapy: Mild Hypertension",
abstract = "In a joint Veterans Administration-National Heart, Lung, and Blood Institute study of mild hypertension, 1,012 men and women, 21 to 50 years of age and with diastolic pressure from 85 to 105 mm Hg, were randomized into two double-blind treatment groups. Subjects in the active group received chlorthalidone or chlorthalidone plus reserpine, while the other subjects received matching placebo tablets. After one year of treatment, the chlorthalidone group had increases of 10.0±1.8 (SE) mg/dL in total cholesterol level, 9.8±5.2 mg/dL in triglyceride level, and 12.6±3.4 mg/dL in low-density lipoprotein-cholesterol level above the changes in the placebo group. There was no difference in high-density lipoprotein changes between the two groups (0.1±0.8 mg/dL). The possible net effect on risk of increasing lipid values while lowering pressure in the long-term treatment of mild hypertension with thiazides or related diuretics must be further evaluated.",
author = "Goldman, {Anne I.} and Steele, {Bernard W} and Schnaper, {Harold W.} and Perry, {H. Mitchell} and Fitz, {Annette E.} and Frohlich, {Edward D.}",
year = "1980",
month = "10",
day = "10",
doi = "10.1001/jama.1980.03310150027023",
language = "English (US)",
volume = "244",
pages = "1691--1695",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "15",

}

TY - JOUR

T1 - Serum Lipoprotein Levels During Chlorthalidone Therapy

T2 - A Veterans Administration-National Heart, Lung, and Blood Institute Cooperative Study on Antihypertensive Therapy: Mild Hypertension

AU - Goldman, Anne I.

AU - Steele, Bernard W

AU - Schnaper, Harold W.

AU - Perry, H. Mitchell

AU - Fitz, Annette E.

AU - Frohlich, Edward D.

PY - 1980/10/10

Y1 - 1980/10/10

N2 - In a joint Veterans Administration-National Heart, Lung, and Blood Institute study of mild hypertension, 1,012 men and women, 21 to 50 years of age and with diastolic pressure from 85 to 105 mm Hg, were randomized into two double-blind treatment groups. Subjects in the active group received chlorthalidone or chlorthalidone plus reserpine, while the other subjects received matching placebo tablets. After one year of treatment, the chlorthalidone group had increases of 10.0±1.8 (SE) mg/dL in total cholesterol level, 9.8±5.2 mg/dL in triglyceride level, and 12.6±3.4 mg/dL in low-density lipoprotein-cholesterol level above the changes in the placebo group. There was no difference in high-density lipoprotein changes between the two groups (0.1±0.8 mg/dL). The possible net effect on risk of increasing lipid values while lowering pressure in the long-term treatment of mild hypertension with thiazides or related diuretics must be further evaluated.

AB - In a joint Veterans Administration-National Heart, Lung, and Blood Institute study of mild hypertension, 1,012 men and women, 21 to 50 years of age and with diastolic pressure from 85 to 105 mm Hg, were randomized into two double-blind treatment groups. Subjects in the active group received chlorthalidone or chlorthalidone plus reserpine, while the other subjects received matching placebo tablets. After one year of treatment, the chlorthalidone group had increases of 10.0±1.8 (SE) mg/dL in total cholesterol level, 9.8±5.2 mg/dL in triglyceride level, and 12.6±3.4 mg/dL in low-density lipoprotein-cholesterol level above the changes in the placebo group. There was no difference in high-density lipoprotein changes between the two groups (0.1±0.8 mg/dL). The possible net effect on risk of increasing lipid values while lowering pressure in the long-term treatment of mild hypertension with thiazides or related diuretics must be further evaluated.

UR - http://www.scopus.com/inward/record.url?scp=84912783482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912783482&partnerID=8YFLogxK

U2 - 10.1001/jama.1980.03310150027023

DO - 10.1001/jama.1980.03310150027023

M3 - Article

AN - SCOPUS:84912783482

VL - 244

SP - 1691

EP - 1695

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 15

ER -